Literature DB >> 10672894

Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.

S B Patten1, C I Neutel.   

Abstract

Reports of corticosteroid-induced adverse psychiatric effects began to appear in the literature soon after the introduction of these medications in the 1950s. Unfortunately, early studies relied on informal classification and measurement procedures and tended to utilise nonspecific descriptive terminology (such as steroid psychosis'). A growing number of contemporary investigations have begun to address these problems. However, the literature remains surprisingly undeveloped from a pharmacoepidemiological perspective, consisting largely of case reports and case series. The objective of this review is to summarise published data concerning corticosteroid-induced adverse psychiatric effects. A clinical perspective will be adopted since opportunities to minimise the impact of corticosteroid-induced adverse effects tend to present themselves most readily within the sphere of clinical management. Some of the psychiatric adverse effects of corticosteroids are mild, and not necessarily clinically significant. However, several serious psychiatric syndromes can be caused by corticosteroids: substance-induced mood disorders (with depressive, manic and mixed features), substance-induced psychotic disorders and delirium. While certain clinical groups may be at greater risk of corticosteroid-induced adverse psychiatric effects, corticosteroid-induced psychiatric toxicity is remarkably unpredictable. The literature regarding prevention and treatment of corticosteroid-induced adverse psychiatric effects is poorly developed. As a result, the emphasis of this review is on clinical and epidemiological evidence linking specific adverse effects to corticosteroid medications. However, clinical reports do provide some practical guidance for prevention and treatment, and these are summarised as well. A variety of pharmacological strategies for treatment and prevention have been proposed. Education and support also appear to be important, and perhaps neglected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672894     DOI: 10.2165/00002018-200022020-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  93 in total

1.  Further observations on mental disturbances associated with cortisone and ACTH therapy.

Authors:  L D CLARK; G C QUARTON; S COBB; W BAUER
Journal:  N Engl J Med       Date:  1953-07-30       Impact factor: 91.245

2.  Adrenocortical suppression presenting with agitated depression, morbid jealousy, and a dementia-like state.

Authors:  F Hassanyeh; R B Murray; H Rodgers
Journal:  Br J Psychiatry       Date:  1991-12       Impact factor: 9.319

3.  Increased arousal from steroids?

Authors:  L E Arnold
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-07       Impact factor: 8.829

4.  Lithium prophylaxis of corticotropin-induced psychosis.

Authors:  W E Falk; M W Mahnke; D C Poskanzer
Journal:  JAMA       Date:  1979-03-09       Impact factor: 56.272

5.  Suicidality and corticosteroid-induced psychosis.

Authors:  P Bräunig; J Bleistein; M L Rao
Journal:  Biol Psychiatry       Date:  1989-06       Impact factor: 13.382

Review 6.  Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus.

Authors:  A J Wysenbeek; L Leibovici; J Zoldan
Journal:  J Rheumatol       Date:  1990-12       Impact factor: 4.666

7.  Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study.

Authors:  S B Patten; J V Williams; E J Love
Journal:  Can J Psychiatry       Date:  1995-06       Impact factor: 4.356

Review 8.  Differential diagnosis and treatment of steroid-induced affective syndromes.

Authors:  R Pies
Journal:  Gen Hosp Psychiatry       Date:  1995-09       Impact factor: 3.238

9.  Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature.

Authors:  D A Lewis; R E Smith
Journal:  J Affect Disord       Date:  1983-11       Impact factor: 4.839

10.  Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.

Authors:  E A Olsen; S C Carson; E A Turney
Journal:  Arch Dermatol       Date:  1992-11
View more
  34 in total

1.  Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review.

Authors:  S Sauerland; M Nagelschmidt; P Mallmann; E A Neugebauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 2.  Beyond the joints: neurological involvement in rheumatoid arthritis.

Authors:  Cesar Ramos-Remus; Sergio Duran-Barragan; Jose Dionisio Castillo-Ortiz
Journal:  Clin Rheumatol       Date:  2011-09-20       Impact factor: 2.980

3.  Could stress cause psychosis in individuals vulnerable to schizophrenia?

Authors:  Cheryl Corcoran; Lilianne Mujica-Parodi; Scott Yale; David Leitman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

4.  And Tell Yourself, "This is not Me, it's the Drug": Coping with the Psychological Impact of Corticosteroid Treatments in Hematology - Further Results from a Pilot Study.

Authors:  Pam McGrath; Mary Anne Patton; Michael Leahy
Journal:  Patient       Date:  2009-03-01       Impact factor: 3.883

Review 5.  Genetic Moderation of Stress Effects on Corticolimbic Circuitry.

Authors:  Ryan Bogdan; David Pagliaccio; David Aa Baranger; Ahmad R Hariri
Journal:  Neuropsychopharmacology       Date:  2015-07-20       Impact factor: 7.853

6.  The neuropsychiatric aspect of Addison's disease: a case report.

Authors:  Mohamed Abdel-Motleb
Journal:  Innov Clin Neurosci       Date:  2012-10

7.  New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study.

Authors:  Katsuji Nishimura; Masako Omori; Eri Sato; Yasuhiro Katsumata; Takahisa Gono; Yasushi Kawaguchi; Masayoshi Harigai; Hisashi Yamanaka; Jun Ishigooka
Journal:  J Neurol       Date:  2014-08-21       Impact factor: 4.849

8.  Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia.

Authors:  Carl J Hochhauser; Michael Lewis; Barton A Kamen; Peter D Cole
Journal:  Support Care Cancer       Date:  2005-09-28       Impact factor: 3.603

Review 9.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 10.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.